Parkinson`S Disease Technology Companies
-
Technologybased in Bethesda, MARYLAND (USA)
Gain Therapeutics is redefining drug discovery with its SEE-Txâ„¢ target identification platform. By identifying and optimizing allosteric binding sites that have never before been targeted, Gain is unlocking new treatment options for ...
-
Technologybased in Providence, RHODE ISLAND (USA)
A spinout of Oxford University, founded by a global team of experienced entrepreneurs, technologists, and neuroscientists, ni2o is continuing the work started by MIT’s Mind Machine Project – developing a revolutionary brain-computer interface (BCI) ...
-
Technologybased in Brooklyn, NEW YORK (USA)
Kaia was born when founders, Konstantin Mehl and Manuel Thurner, came together on their mission to find a more effective way to manage chronic back pain. After years of personal suffering from this issue, the founder duo discovered the solution: ...
-
Technologybased in Roden, NETHERLANDS
Pure Inhalation Medication Systems (PureIMS) is a clinical stage pharmaceutical company focused on developing and commercializing innovative inhaled therapies, based on its proprietary dry powder inhaler Cyclops. The focus is on the treatment of ...
Levodopa Cyclops - Dry Powder Inhaler
Levodopa Cyclops™ is a levodopa dry powder inhaler for the fast and reliable relief of OFF episodes in Parkinson’s disease. As such, Levodopa Cyclops™ answers a major unmet medical ...
CONTACT SUPPLIER -
Technologybased in Lynnwood, WASHINGTON (USA)
Kurve Therapeutics drug delivery technology is designed to target the most difficult part of the treatment process - getting medication through the blood-brain barrier and into the brain. Kurve Therapeutics has 18 peer-reviewed publications of ...
-
Technologybased in Yongin-si, SOUTH KOREA
Vivozon is a global innovative drug development company established in 2008. We built an efficacy-based new drug discovery system that is clearly distinct from the existing new drug development paradigm, and discovered the non- narcotic analgesic ...
-
Technologybased in Rye Brook, NEW YORK (USA)
Curemark is a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of neurological disorders. Our pipeline includes our lead drug candidate, CM-AT, which is in a Phase III clinical trial for Autism, and is ...
Treatment for Parkinson’s-Related Dyskinesia
Parkinson’s disease (PD), a progressive disorder of the nervous system with both motor and non-motor symptoms, currently affects one million people in the United States, with 50,000-60,000 new ...
CONTACT SUPPLIER -
Technologybased in Sollentuna, SWEDEN
Sensidose AB is a pharmaceutical company that has developed an innovative new system for individualized dosing of pharmaceutical tablets, allowing for fine-tuned, precision drug therapy. The system is composed of “micro”- tablets, sub-pharmaceutical ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you